Hemoglobin A1c (HbA1c) Testing Global Market Report 2024

Description

Hemoglobin A1c (HbA1c) testing measures the percentage of hemoglobin with glucose attached, providing an indication of average blood glucose levels over the past 2 to 3 months. It is used to monitor long-term glucose control in diabetic patients and to diagnose diabetes and prediabetes.

The main types of HbA1c testing are laboratory-based testing and point-of-care (PoC) testing. Laboratory-based testing is conducted in a lab setting where blood samples are analyzed using advanced equipment. Product types for this testing include instruments, reagents, kits, and technologies. These technologies encompass immunoassays, chromatography, enzymatic assays, boronate affinity chromatography, high-performance liquid chromatography, and others. End users of HbA1c testing include hospitals and clinics, diagnostic laboratories, homecare settings, and other medical environments.

The hemoglobin A1c (HbA1c) testing market research report is one of a series of new reports from the business research company that provides hemoglobin A1c (HbA1c) testing market statistics, including hemoglobin A1c (HbA1c) testing industry global market size, regional shares, competitors with an hemoglobin A1c (HbA1c) testing market share, detailed hemoglobin A1c (HbA1c) testing market segments, market trends and opportunities, and any further data you may need to thrive in the hemoglobin A1c (HbA1c) testing industry. This hemoglobin A1c (HbA1c) testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hemoglobin A1c (HbA1c) testing market size has grown rapidly in recent years. It will grow from $1.66 billion in 2023 to $1.83 billion in 2024 at a compound annual growth rate (CAGR) of 10.4%. The growth during the historic period can be attributed to several factors, the rising prevalence of diabetes, increased awareness and screening programs, expanding government initiatives and healthcare policies, development of healthcare infrastructure, a growing aging population, improved diagnostic accuracy, and greater adoption of point-of-care testing.

The hemoglobin A1c (HbA1c) testing market size is expected to see rapid growth in the next few years. It will grow to $2.74 billion in 2028 at a compound annual growth rate (CAGR) of 10.6%. The anticipated growth during the forecast period can be attributed to several factors, the rising prevalence of lifestyle diseases, increased emphasis on preventive healthcare, expansion into emerging markets, growing focus on personalized medicine and patient-centric care, supportive regulatory and reimbursement policies, and advancements in telemedicine and remote monitoring. Key trends expected to drive this growth include technological advancements, integration with digital health platforms, progress in non-invasive testing technologies, expansion in telehealth services, and enhancements in remote patient monitoring.

The growing prevalence of diabetes is expected to drive the expansion of the hemoglobin A1c (HbA1c) testing market. Diabetes is a chronic condition where the body struggles to regulate blood glucose levels due to inadequate insulin production or insulin resistance. The rise in diabetes cases is attributed to factors such as poor diet-particularly high consumption of processed foods and sugary drinks-and sedentary lifestyles with minimal physical activity. Additionally, the aging population and genetic predisposition increase the likelihood of developing diabetes. HbA1c testing is essential for monitoring long-term blood glucose control by measuring average blood sugar levels over the past 2-3 months. For example, data from The Lancet in June 2023 projected that global diabetes cases would grow from 529 million in 2021 to 1.3 billion by 2050. Consequently, the increasing prevalence of diabetes will fuel the growth of the HbA1c testing market.

Leading companies in the HbA1c testing market are concentrating on developing automated analyzers, such as those using high-performance liquid chromatography (HPLC) technology, to improve accuracy and efficiency in diabetes diagnosis and monitoring. HPLC-based solutions are advanced methods for precisely measuring hemoglobin variants in blood, which helps in monitoring long-term glucose control in diabetic patients. For instance, in June 2021, Trivitron Healthcare Private Limited, an India-based medical technology company, introduced the NANO H5 and NANO H110. The NANO H5 is a compact, automated HPLC analyzer that quantifies glycated hemoglobin (HbA1c) in whole blood with a processing time of 130 seconds, allowing for rapid laboratory results and the capability to process up to five samples simultaneously. The NANO H110 is another compact, automated HPLC analyzer with dual test modes for both HbA1c and Hb Variant detection. It features advanced components such as a barcode scanner and cap piercing, with a high sample capacity of 110, making it suitable for medium to large laboratories.

In January 2024, Roche Holding AG, a Swiss pharmaceutical and diagnostics company, acquired point-of-care (POC) technology from LumiraDx for $350 million. This acquisition aims to expand Roche's diagnostics portfolio and enhance its capabilities in decentralized healthcare settings, providing quick and reliable tests, including the CE-marked HbA1c test, without requiring specialized storage. LumiraDx is a UK-based company specializing in point-of-care (POC) technology and offering immunoassay and clinical chemistry tests for HbA1c.

Major companies operating in the hemoglobin A1c (HbA1c) testing market are Roche Holding AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers, Tosoh Corporation, Hitachi High-Technologies Corporation, Beckman Coulter Inc, Sysmex Corporation, Bio Rad Laboratories Inc, ARKRAY Inc, Randox Laboratories Ltd, Ortho Clinical Diagnostics, Agappe Diagnostics Ltd, SEKISUI Diagnostics LLC, Helena Laboratories, Transasia Bio Medicals Ltd, EKF Diagnostics, Trinity Biotech plc, HemoCue AB, CPC Diagnostics Pvt Ltd, PTS Diagnostics, Menarini Diagnostics srl, Diazyme Laboratories Inc, Osang HealthCare Co Ltd, Eurolyser Diagnostica GmbH, DiaSys Diagnostic Systems GmbH

North America was the largest region in the hemoglobin A1c (HbA1c) testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hemoglobin A1c (HbA1c) testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the hemoglobin A1c (HbA1c) testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The hemoglobin A1c (HbA1c) testing market consists of revenues earned by entities by providing services such as home monitoring services, remote patient monitoring solutions, specialized HbA1c assay development, telehealth HbA1c monitoring, and personalized treatment management consulting. The market value includes the value of related goods sold by the service provider or included within the service offering. The hemoglobin A1c (HbA1c) testing market also includes sales of diagnostic reagents, test cartridges, automated analyzers, and calibration standards. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hemoglobin A1c (HbA1c) Testing Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hemoglobin A1c (HbA1c) testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hemoglobin A1c (HbA1c) testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The hemoglobin A1c (HbA1c) testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Laboratory Based Testing; Point Of Care (PoC) Testing
2) By Product Type: Instruments; Reagents; Kits
3) By Technology: Immunoassays; Chromatography; Enzymatic Assays; Boronate Affinity Chromatography; High Performance Liquid Chromatography; Other Technologies
4) By End User: Hospitals And Clinics; Diagnostic Laboratories; Homecare Settings; Other End Users
Companies Mentioned: Roche Holding AG; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Siemens Healthineers
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r19930

1. Executive Summary

2. Hemoglobin A1c (HbA1c) Testing Market Characteristics

3. Hemoglobin A1c (HbA1c) Testing Market Trends And Strategies

4. Hemoglobin A1c (HbA1c) Testing Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Hemoglobin A1c (HbA1c) Testing Market Size and Growth

5.1. Global Hemoglobin A1c (HbA1c) Testing Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Hemoglobin A1c (HbA1c) Testing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Hemoglobin A1c (HbA1c) Testing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Hemoglobin A1c (HbA1c) Testing Market Segmentation

6.1. Global Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Laboratory Based Testing
Point Of Care (Poc) Testing
6.2. Global Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Instruments
Reagents
Kits
6.3. Global Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Immunoassays
Chromatography
Enzymatic Assays
Boronate Affinity Chromatography
High Performance Liquid Chromatography
Other Technologies
6.4. Global Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospitals And Clinics
Diagnostic Laboratories
Homecare Settings
Other End Users

7. Hemoglobin A1c (HbA1c) Testing Market Regional And Country Analysis

7.1. Global Hemoglobin A1c (HbA1c) Testing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Hemoglobin A1c (HbA1c) Testing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Hemoglobin A1c (HbA1c) Testing Market

8.1. Asia-Pacific Hemoglobin A1c (HbA1c) Testing Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Hemoglobin A1c (HbA1c) Testing Market

9.1. China Hemoglobin A1c (HbA1c) Testing Market Overview
9.2. China Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Hemoglobin A1c (HbA1c) Testing Market

10.1. India Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Hemoglobin A1c (HbA1c) Testing Market

11.1. Japan Hemoglobin A1c (HbA1c) Testing Market Overview
11.2. Japan Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Hemoglobin A1c (HbA1c) Testing Market

12.1. Australia Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Hemoglobin A1c (HbA1c) Testing Market

13.1. Indonesia Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Hemoglobin A1c (HbA1c) Testing Market

14.1. South Korea Hemoglobin A1c (HbA1c) Testing Market Overview
14.2. South Korea Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Hemoglobin A1c (HbA1c) Testing Market

15.1. Western Europe Hemoglobin A1c (HbA1c) Testing Market Overview
15.2. Western Europe Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Hemoglobin A1c (HbA1c) Testing Market

16.1. UK Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Hemoglobin A1c (HbA1c) Testing Market

17.1. Germany Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Hemoglobin A1c (HbA1c) Testing Market

18.1. France Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Hemoglobin A1c (HbA1c) Testing Market

19.1. Italy Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Hemoglobin A1c (HbA1c) Testing Market

20.1. Spain Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Hemoglobin A1c (HbA1c) Testing Market

21.1. Eastern Europe Hemoglobin A1c (HbA1c) Testing Market Overview
21.2. Eastern Europe Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Hemoglobin A1c (HbA1c) Testing Market

22.1. Russia Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Hemoglobin A1c (HbA1c) Testing Market

23.1. North America Hemoglobin A1c (HbA1c) Testing Market Overview
23.2. North America Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Hemoglobin A1c (HbA1c) Testing Market

24.1. USA Hemoglobin A1c (HbA1c) Testing Market Overview
24.2. USA Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Hemoglobin A1c (HbA1c) Testing Market

25.1. Canada Hemoglobin A1c (HbA1c) Testing Market Overview
25.2. Canada Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Hemoglobin A1c (HbA1c) Testing Market

26.1. South America Hemoglobin A1c (HbA1c) Testing Market Overview
26.2. South America Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Hemoglobin A1c (HbA1c) Testing Market

27.1. Brazil Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Hemoglobin A1c (HbA1c) Testing Market

28.1. Middle East Hemoglobin A1c (HbA1c) Testing Market Overview
28.2. Middle East Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Hemoglobin A1c (HbA1c) Testing Market

29.1. Africa Hemoglobin A1c (HbA1c) Testing Market Overview
29.2. Africa Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Hemoglobin A1c (HbA1c) Testing Market Competitive Landscape And Company Profiles

30.1. Hemoglobin A1c (HbA1c) Testing Market Competitive Landscape
30.2. Hemoglobin A1c (HbA1c) Testing Market Company Profiles
- 30.2.1. Roche Holding AG
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Thermo Fisher Scientific Inc.
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Abbott Laboratories
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Danaher Corporation
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Siemens Healthineers
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Hemoglobin A1c (HbA1c) Testing Market Other Major And Innovative Companies

31.1. Tosoh Corporation
31.2. Hitachi High-Technologies Corporation
31.3. Beckman Coulter Inc
31.4. Sysmex Corporation
31.5. Bio Rad Laboratories Inc
31.6. ARKRAY Inc
31.7. Randox Laboratories Ltd
31.8. Ortho Clinical Diagnostics
31.9. Agappe Diagnostics Ltd
31.10. SEKISUI Diagnostics LLC
31.11. Helena Laboratories
31.12. Transasia Bio Medicals Ltd
31.13. EKF Diagnostics
31.14. Trinity Biotech plc
31.15. HemoCue AB

32. Global Hemoglobin A1c (HbA1c) Testing Market Competitive Benchmarking

33. Global Hemoglobin A1c (HbA1c) Testing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Hemoglobin A1c (HbA1c) Testing Market

35. Hemoglobin A1c (HbA1c) Testing Market Future Outlook and Potential Analysis

35.1 Hemoglobin A1c (HbA1c) Testing Market In 2028 - Countries Offering Most New Opportunities
35.2 Hemoglobin A1c (HbA1c) Testing Market In 2028 - Segments Offering Most New Opportunities
35.3 Hemoglobin A1c (HbA1c) Testing Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer